Business Segments Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.89 USD | +0.52% |
|
+7.57% | -17.72% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Discovery and Safety Assessment (DSA) | 1.84B | 2.11B | 2.45B | 2.62B | 2.45B | |||||
CAPEX | -106M | -101M | -190M | -205M | -128M | |||||
D&A | 169M | 177M | 179M | 175M | 191M | |||||
Operating Income | 326M | 407M | 533M | 606M | 443M | |||||
Research Models and Services (RMS) | 571M | 690M | 739M | 792M | 829M | |||||
CAPEX | -29.49M | -61.19M | -44.14M | -52.82M | -64.13M | |||||
D&A | 37.08M | 39.12M | 49.27M | 55.57M | 73.81M | |||||
Operating Income | 103M | 167M | 160M | 155M | 114M | |||||
Manufacturing Solutions (Manufacturing) | 515M | 742M | 790M | 721M | 769M | |||||
CAPEX | -26.29M | -58.88M | -87.08M | -58.13M | -38.5M | |||||
D&A | 25.9M | 46.2M | 72.95M | 79.98M | 89.96M | |||||
Operating Income | 181M | 246M | 167M | 88.33M | -71.45M | |||||
CAPEX | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -34.11M | -43.02M | - | - | - | |||||
Operating Income | -73.81M | -92.46M | - | - | - | |||||
Operating Income | -26.56M | -25.37M | - | - | - | |||||
Operating Income | -18.91M | -18.45M | - | - | - | |||||
Operating Income | -3.02M | -2.97M | - | - | - | |||||
Operating Income | -7.02M | -17.68M | - | - | - | |||||
CAPEX | -5.13M | -7.23M | -3.95M | -2.68M | -1.98M | |||||
D&A | 3.02M | 2.97M | 2.18M | 3.85M | 6.84M | |||||
Operating Income | - | - | -209M | -232M | -258M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S) | 1.63B | 1.93B | 2.34B | 2.35B | 2.24B | |||||
Total Assets | 628M | 755M | 896M | 964M | 942M | |||||
Europe | 829M | 1.04B | 1.03B | 1.08B | 1.08B | |||||
Total Assets | 286M | 323M | 349M | 407M | 413M | |||||
Canada | 306M | 339M | 399M | 487M | 482M | |||||
Total Assets | 145M | 145M | 135M | 157M | 147M | |||||
Asia Pacific | 155M | 223M | 193M | 201M | 197M | |||||
Total Assets | 62.93M | 64.86M | 82.78M | 74.6M | 66.05M | |||||
Other | 6.13M | 7.29M | 9.96M | 16.85M | 52.82M | |||||
Total Assets | 1.92M | 2.12M | 1.98M | 36.1M | 36.34M | |||||
Japan | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition